0.63
price up icon0.00%   0.00
 
loading
전일 마감가:
$0.63
열려 있는:
$0.62
하루 거래량:
200.74K
Relative Volume:
0.27
시가총액:
$4.25M
수익:
$72,100
순이익/손실:
$-3.60M
주가수익비율:
-0.5294
EPS:
-1.19
순현금흐름:
$-3.37M
1주 성능:
+1.97%
1개월 성능:
+41.76%
6개월 성능:
-29.21%
1년 성능:
-35.98%
1일 변동 폭
Value
$0.60
$0.6399
1주일 범위
Value
$0.5968
$0.66
52주 변동 폭
Value
$0.4101
$4.50

Silo Pharma Inc Stock (SILO) Company Profile

Name
명칭
Silo Pharma Inc
Name
전화
(718) 400-9031
Name
주소
677 N. WASHINGTON BLVD, SARASOTA
Name
직원
3
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
SILO's Discussions on Twitter

SILO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
 icon
SILO
SILO PHARMA INC
1.71 17.96M 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
0.3701 544.73M 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.48 372.90M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.1439 316.76M 2.07B -1.42B -1.37B -0.6765
 icon
SHMD
Schmid Group N V
2.7896 118.42M 0 0 0 0.00
 icon
DAVEW
Dave Inc
1.86 0 0 0 0 0.00

Silo Pharma Inc 주식(SILO)의 최신 뉴스

pulisher
Jun 16, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Jun 16, 2025
pulisher
Jun 11, 2025

SILO Pharma Secures USPTO Approval for Key Patent Enhancing SPC-15 Protection | SILO Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Silo Pharma receives patent allowance for PTSD treatment technology - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Silo Pharma receives patent allowance for PTSD treatment technology By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Silo Pharma, Inc. Receives Notice of Allowance for Patent Strengthening SPC-15 Treatment for PTSD - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Breakthrough PTSD Drug Patent: Silo Pharma's Intranasal Treatment Advances Toward Clinical Trials - Stock Titan

Jun 11, 2025
pulisher
Jun 07, 2025

Silo Pharma approves purchase of Bitcoin as treasury reserve asset; shares up - MSN

Jun 07, 2025
pulisher
Jun 05, 2025

Silo Pharma allocates $1 million to Bitcoin holdings By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Is Silo Pharma moving to BIO Protocol? No - Binance

Jun 05, 2025
pulisher
Jun 05, 2025

Silo Pharma's Board Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset; Shares Rise - MarketScreener

Jun 05, 2025
pulisher
Jun 05, 2025

Silo Pharma (SILO) Allocates $1 Million for Bitcoin Investment | - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Silo Pharma allocates $1 million to Bitcoin holdings - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

Silo Pharma stock surges on Bitcoin reserve move - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

Silo Pharma stock surges on Bitcoin reserve move By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset - The Manila Times

Jun 05, 2025
pulisher
Jun 05, 2025

Silo Pharma, Inc. Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset - Nasdaq

Jun 05, 2025
pulisher
Jun 05, 2025

Biotech Makes Bold Move: Silo Pharma Commits $1M to Bitcoin as Inflation Shield - Stock Titan

Jun 05, 2025
pulisher
Jun 05, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jun 05, 2025
pulisher
May 27, 2025

Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket - Benzinga

May 27, 2025
pulisher
May 27, 2025

Silo Pharma's (NASDAQ:SILO) Groundbreaking Therapies Could Change The Treatment Landscape For PTSD, Fibromyalgia, MS & Alzheimer’s - simplywall.st

May 27, 2025
pulisher
May 21, 2025

Silo Pharma advances PTSD treatment with new drug-device study By Investing.com - Investing.com South Africa

May 21, 2025
pulisher
May 21, 2025

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15 - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Silo Pharma stock plunges to 52-week low of $0.47 By Investing.com - Investing.com Canada

May 21, 2025
pulisher
May 21, 2025

Silo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drug - Seeking Alpha

May 21, 2025
pulisher
May 21, 2025

SiloPharma (SILO) Advances SPC-15 with New Drug-Device Study Agreement | SILO Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Silo Pharma Collaborates With Resyca for Drug-Device Study of PTSD Drug SPC-15 - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Silo Pharma advances PTSD treatment with new drug-device study - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

Breakthrough PTSD Treatment: Silo Pharma's Brain-Targeting Drug Delivery System Heads to FDA - Stock Titan

May 21, 2025
pulisher
May 21, 2025

Silicon Valley - FinancialContent

May 21, 2025
pulisher
May 17, 2025

Silo Pharma Announces Closing of $2 Million Public Offering - GlobeNewswire

May 17, 2025
pulisher
May 16, 2025

Silo Pharma Completes Public Offering, Raises $1.56 Million - TipRanks

May 16, 2025
pulisher
May 16, 2025

Silo Pharma, Inc. Completes Public Offering Raising Approximately $2 Million - Nasdaq

May 16, 2025
pulisher
May 16, 2025

Silo Pharma Announces Closing Of $2 Million Public Offering - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

SEC Form 424B4 filed by Silo Pharma Inc. - Quantisnow

May 16, 2025
pulisher
May 15, 2025

Silo Pharma sets public offering at $0.60 per share and warrant - Investing.com Nigeria

May 15, 2025
pulisher
May 15, 2025

SiloPharma (SILO) Sets $2 Million Public Offering with Warrants - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Silo Pharma Announces Pricing of $2 Million Public Offering - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Silo Pharma, Inc. Prices Public Offering of 3,333,338 Shares with Associated Warrants - Nasdaq

May 15, 2025
pulisher
May 15, 2025

Silo Pharma Announces $2M Offering with 5-Year Warrants: Complete Details of Latest Financing Round - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Silo Pharma advances in PTSD nasal therapy trials By Investing.com - Investing.com Canada

May 15, 2025
pulisher
May 15, 2025

Silo Pharma Retail Buzz Surges On FDA Toxicology Study Plans For PTSD Treatment - Asianet Newsable

May 15, 2025
pulisher
May 14, 2025

Silo Pharma (SILO) Partners with Veloxity Labs for Key Drug Stud - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Silo Pharma advances PTSD treatment study with Veloxity Labs By Investing.com - Investing.com Canada

May 14, 2025
pulisher
May 14, 2025

Silo Pharma (SILO) Partners with Veloxity Labs for Key Drug Study | SILO Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Silo Pharma advances PTSD treatment study with Veloxity Labs - Investing.com Australia

May 14, 2025

Silo Pharma Inc (SILO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Silo Pharma Inc 주식 (SILO) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Weisblum Eric
CEO and President
Dec 13 '24
Buy
0.84
2,500
2,097
187,932
Weisblum Eric
CEO and President
Nov 20 '24
Buy
0.95
2,500
2,375
182,932
Weisblum Eric
CEO and President
Nov 22 '24
Buy
0.90
2,500
2,250
185,432
$20.78
price up icon 0.61%
$35.68
price down icon 0.91%
$21.35
price up icon 0.33%
$97.83
price down icon 2.86%
$108.08
price up icon 1.47%
biotechnology ONC
$243.77
price up icon 0.74%
자본화:     |  볼륨(24시간):